Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 126

Related Citations for PubMed (Select 23307959)

1.

Effectiveness of palmitoylethanolamide on endothelial dysfunction in ocular hypertensive patients: a randomized, placebo-controlled cross-over study.

Strobbe E, Cellini M, Campos EC.

Invest Ophthalmol Vis Sci. 2013 Feb 1;54(2):968-73. doi: 10.1167/iovs.12-10899.

2.

Ocular hypotensive effect of oral palmitoyl-ethanolamide: a clinical trial.

Gagliano C, Ortisi E, Pulvirenti L, Reibaldi M, Scollo D, Amato R, Avitabile T, Longo A.

Invest Ophthalmol Vis Sci. 2011 Aug 3;52(9):6096-100. doi: 10.1167/iovs.10-7057.

3.

Effects of GH replacement on endothelial function and large-artery stiffness in GH-deficient adults: a randomized, double-blind, placebo-controlled study.

Smith JC, Evans LM, Wilkinson I, Goodfellow J, Cockcroft JR, Scanlon MF, Davies JS.

Clin Endocrinol (Oxf). 2002 Apr;56(4):493-501.

PMID:
11966742
4.

Effect of estrogen on endothelial dysfunction in postmenopausal women with diabetes.

Lee SJ, Lee DW, Kim KS, Lee IK.

Diabetes Res Clin Pract. 2001 Dec;54 Suppl 2:S81-92.

PMID:
11733113
5.

Effect of fluvastatin on endothelium-dependent brachial artery vasodilation in patients after renal transplantation.

Hausberg M, Kosch M, Stam F, Heidenreich S, Kisters K, Rahn KH, Barenbrock M.

Kidney Int. 2001 Apr;59(4):1473-9.

6.

Effects of vitamin E on chronic and acute endothelial dysfunction in smokers.

Neunteufl T, Priglinger U, Heher S, Zehetgruber M, Söregi G, Lehr S, Huber K, Maurer G, Weidinger F, Kostner K.

J Am Coll Cardiol. 2000 Feb;35(2):277-83.

7.

Different galenic formulations of fluvastatin have equal lipid-lowering potential but differ in reducing lipemia-induced endothelial dysfunction.

Westphal S, Abletshauser C, Luley C.

Coron Artery Dis. 2009 Jan;20(1):81-5. doi: 10.1097/MCA.0b013e32831a8811.

PMID:
19060628
8.

Differential effects of heart rate reduction by atenolol or ivabradine on peripheral endothelial function in type 2 diabetic patients.

Nerla R, Di Franco A, Milo M, Pitocco D, Zaccardi F, Tarzia P, Sarullo FM, Villano A, Russo G, Stazi A, Ghirlanda G, Lanza GA, Crea F.

Heart. 2012 Dec;98(24):1812-6. doi: 10.1136/heartjnl-2012-302795. Epub 2012 Oct 19.

PMID:
23086971
9.

Reduced endothelial progenitor cells and brachial artery flow-mediated dilation as evidence of endothelial dysfunction in ocular hypertension and primary open-angle glaucoma.

Fadini GP, Pagano C, Baesso I, Kotsafti O, Doro D, de Kreutzenberg SV, Avogaro A, Agostini C, Dorigo MT.

Acta Ophthalmol. 2010 Feb;88(1):135-41. doi: 10.1111/j.1755-3768.2009.01573.x. Epub 2009 Jul 22.

PMID:
19549102
10.

Targeting inflammation using salsalate in patients with type 2 diabetes: effects on flow-mediated dilation (TINSAL-FMD).

Goldfine AB, Buck JS, Desouza C, Fonseca V, Chen YD, Shoelson SE, Jablonski KA, Creager MA; TINSAL-FMD (Targeting Inflammation Using Salsalate in Type 2 Diabetes–Flow-Mediated Dilation) Ancillary Study Team.

Diabetes Care. 2013 Dec;36(12):4132-9. doi: 10.2337/dc13-0859. Epub 2013 Oct 15.

11.

Effect of nebivolol and atenolol on brachial artery flow-mediated vasodilation in patients with coronary artery disease.

Lekakis JP, Protogerou A, Papamichael C, Vamvakou G, Ikonomidis I, Fici F, Mavrikakis M.

Cardiovasc Drugs Ther. 2005 Aug;19(4):277-81. Erratum in: Cardiovasc Drugs Ther. 2010 Feb;24(1):93. Iconomidis, Ignatios [corrected to Ikonomidis, Ignatios].

PMID:
16187009
12.

Effects of oral niacin on endothelial dysfunction in patients with coronary artery disease: results of the randomized, double-blind, placebo-controlled INEF study.

Warnholtz A, Wild P, Ostad MA, Elsner V, Stieber F, Schinzel R, Walter U, Peetz D, Lackner K, Blankenberg S, Munzel T.

Atherosclerosis. 2009 May;204(1):216-21. doi: 10.1016/j.atherosclerosis.2008.08.003. Epub 2008 Aug 12.

PMID:
18822413
13.

Effect of chelation therapy on endothelial function in patients with coronary artery disease: PATCH substudy.

Anderson TJ, Hubacek J, Wyse DG, Knudtson ML.

J Am Coll Cardiol. 2003 Feb 5;41(3):420-5.

PMID:
12575969
14.

Apolipoprotein B-48 as a determinant of endothelial function in obese subjects with type 2 diabetes mellitus: effect of fenofibrate treatment.

Chan DC, Wong AT, Yamashita S, Watts GF.

Atherosclerosis. 2012 Apr;221(2):484-9. doi: 10.1016/j.atherosclerosis.2012.01.029. Epub 2012 Jan 26.

PMID:
22341868
15.

High-dose atorvastatin in peripheral arterial disease (PAD): effect on endothelial function, intima-media-thickness and local progression of PAD. An open randomized controlled pilot trial.

Spring S, Simon R, van der Loo B, Kovacevic T, Brockes C, Rousson V, Amann-Vesti B, Koppensteiner R.

Thromb Haemost. 2008 Jan;99(1):182-9. doi: 10.1160/TH07-04-0265.

PMID:
18217152
16.

Glaucoma is associated with peripheral vascular endothelial dysfunction.

Su WW, Cheng ST, Ho WJ, Tsay PK, Wu SC, Chang SH.

Ophthalmology. 2008 Jul;115(7):1173-1178.e1. Epub 2008 Feb 20.

PMID:
18076992
17.

Effects of Pycnogenol on endothelial function in patients with stable coronary artery disease: a double-blind, randomized, placebo-controlled, cross-over study.

Enseleit F, Sudano I, Périat D, Winnik S, Wolfrum M, Flammer AJ, Fröhlich GM, Kaiser P, Hirt A, Haile SR, Krasniqi N, Matter CM, Uhlenhut K, Högger P, Neidhart M, Lüscher TF, Ruschitzka F, Noll G.

Eur Heart J. 2012 Jul;33(13):1589-97. doi: 10.1093/eurheartj/ehr482. Epub 2012 Jan 11.

18.

Endothelium-dependent responses in patients with hypercholesterolemic coronary artery disease under the effects of simvastatin and enalapril, either separately or combined.

Esper RJ, Machado R, Vilariño J, Cacharrón JL, Ingino CA, García Guiñazú CA, Bereziuk E, Bolaño AL, Suarez DH.

Am Heart J. 2000 Oct;140(4):684-9.

PMID:
11011346
19.

Folic acid improves arterial endothelial function in adults with hyperhomocystinemia.

Woo KS, Chook P, Lolin YI, Sanderson JE, Metreweli C, Celermajer DS.

J Am Coll Cardiol. 1999 Dec;34(7):2002-6.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk